加拿大非游离皮瓣乳房手术血栓预防与氨甲环酸使用全国调查
该研究于2025年向加拿大整形外科医生发放匿名在线问卷,评估九种常见非游离皮瓣乳房手术的血栓预防和氨甲环酸(TXA)实践。 fellowship培训、TXA使用和指南使用预测积极预防行为,而更多临床经验预测保守行为。
要点
- 非游离皮瓣乳房手术血栓预防策略差异大,最常用启动阈值为手术2-3小时(35%)。
- 机械预防在隆乳术中最少用(38%),药物预防在带蒂皮瓣重建中最常用(46%)。
- TXA使用与药物血栓预防(OR 8.0)和更早启动预防(OR 27.2)相关。
核心结论
- 非游离皮瓣乳房手术的血栓预防管理不一致,需要共识支持循证实践。
主要发现
- 79%报告常规使用VTE风险评估工具,但预防实践差异大。
- 最常见预防启动阈值为手术时长2-3小时(35%)。
- 机械预防在隆乳术中最少用(38%),药物预防在带蒂皮瓣重建中最常用(46%)。
- Fellowship培训医生更早启动血栓预防(OR 5.8,95%CI 1.8-19.1),经验超过10年者延迟启动(OR 8.2,95%CI 1.8-38.0)。
- TXA使用与药物血栓预防使用(OR 8.0,95%CI 1.8-86.0)和更早启动预防(OR 27.2,95%CI 2.7-273.1)相关。
临床怎么用
- 临床应常规评估VTE风险,根据手术时长等因素个体化决定血栓预防启动时机。
- 可考虑将TXA使用与药物血栓预防结合,以支持更积极的预防策略。
局限性
- 应答率34%,可能存在应答偏倚;为自报实践调查,非客观临床数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Patients undergoing breast surgery are at risk of venous thromboembolism (VTE), but most literature examining thromboprophylaxis management in breast surgery focuses on free flap reconstruction. We evaluated thromboprophylaxis and tranexamic acid (TXA) practices among Canadian plastic surgeons for non-free flap breast surgeries. MATERIALS/METHODS: An anonymous online survey was distributed to Canadian plastic surgeons in 2025. Data collected included demographics, VTE prophylaxis strategies, and TXA use across nine commonly-performed non-free flap breast procedures. Predictors of thromboprophylaxis and TXA use were identified. RESULTS: Sixty-five surgeons nationwide (34% response rate) completed the survey; 43% had completed a breast fellowship. Although 79% reported regular use of VTE risk tools, prophylaxis practices varied widely. The most common threshold for initiating prophylaxis was 2-3 h of operative duration (35%). Mechanical prophylaxis was the least common in breast augmentation (38%), and chemical prophylaxis was the most common in pedicled flap reconstruction (46%). Fellowship-trained surgeons initiated thromboprophylaxis at earlier operative times (OR 5.8, 95% CI 1.8-19.1), whereas those with more than 10 years of experience delayed initiation (OR 8.2, 95% CI 1.8-38.0). Self-reported "guideline-adherent" surgeons were more likely to use mechanical prophylaxis than surgeons who did not report guideline usage. TXA use correlated with chemical thromboprophylaxis usage (OR 8.0, 95% CI 1.8-86.0) and earlier prophylaxis initiation (OR 27.2, 95% CI 2.7-273.1). CONCLUSION: Thromboprophylaxis management is inconsistent in non-free flap breast surgery. Fellowship training, TXA utilization, and guideline usage predicted proactive prophylaxis approaches, whereas more clinical experience predicted conservative behaviors. Prophylaxis consensus is needed to support consistent, evidence-based care.
引用
- Haas J, Zhou T, Yuen K, et al. National survey of thromboprophylaxis management and tranexamic acid utilization in patients undergoing non-free flap breast surgery. J Plast Reconstr Aesthet Surg. 2026. PMID: 41558155. doi:10.1016/j.bjps.2025.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。